Learn
Study authors write, "Results showed significant and large reductions in the intensity of traumatic stress, depression, and anxiety symptoms from...
“Cigarette smoking remains one of the most difficult addictions to treat and contributes to more deaths than all the other...
This week in psychedelic business news: More psychedelic clinical trials are green-lighted, new partnerships inked, and Beckley Psytech successfully completes...
Although based in Canada, the company is building a clinical network of therapists trained in ketamine-assisted psychotherapy across the United...
Recent ayahuasca study concludes mixed messages in attempt to determine if the ancient plant medicine has power to change personality,...
The company is also pursuing psilocybin as a possible treatment for rare cancers, but they see huge potential in researching...
"A mushroom is not a pharmaceutical product," CEO Evan Levine stresses, and explains why his company's method of biologically engineering...
The trial will build on Diamond Therapeutic's previous animal research that demonstrated how non-hallucinogenic doses of psilocybin hold the potential...
The filmmaker behind the Netflix hit tells us a sequel or a series is on the way, as well as...
The company will use proceeds of the fundraising round to complete its ongoing Phase 1B trial on low-dose psilocybin in...